Food and Drug Administration has flagged BPC-157 among bulk substances reviewed for compounding, and long-term human safety has not been established
Future research will need to clarify the extent to which these mechanisms are translatable into clinical practice and what their long-term implications may be for the human population
Two structural modifications (C18 fatty acid chain enabling albumin binding, and a substitution at position 8 conferring DPP-4 resistance) extend its half-life to approximately 1 week, enabling once-weekly subcutaneous dosing
It must be stored upright and not within reach of the freezer or cooling elements
03Anota lote, solvente, concentracin final, fecha y responsable en el registro interno de investigacin
Consult Professionals: Work with healthcare providers at Prestige Medical Group, to ensure your treatment plan is safe and effective